ATE521892T1 - Systeme und verfahren zum identifizieren des organtransplantationsrisikos - Google Patents

Systeme und verfahren zum identifizieren des organtransplantationsrisikos

Info

Publication number
ATE521892T1
ATE521892T1 AT03728889T AT03728889T ATE521892T1 AT E521892 T1 ATE521892 T1 AT E521892T1 AT 03728889 T AT03728889 T AT 03728889T AT 03728889 T AT03728889 T AT 03728889T AT E521892 T1 ATE521892 T1 AT E521892T1
Authority
AT
Austria
Prior art keywords
methods
systems
organ transplantation
present
rejection
Prior art date
Application number
AT03728889T
Other languages
English (en)
Inventor
Huaizhong Hu
Alice Puchalski
Brian Aizenstein
Original Assignee
Renovar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovar Inc filed Critical Renovar Inc
Application granted granted Critical
Publication of ATE521892T1 publication Critical patent/ATE521892T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03728889T 2002-05-14 2003-05-14 Systeme und verfahren zum identifizieren des organtransplantationsrisikos ATE521892T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38056902P 2002-05-14 2002-05-14
US10/313,807 US7244555B2 (en) 2002-05-14 2002-12-06 Systems and methods for identifying organ transplant risk
PCT/US2003/015104 WO2003098185A2 (en) 2002-05-14 2003-05-14 Systems and methods for identifying organ transplant risk

Publications (1)

Publication Number Publication Date
ATE521892T1 true ATE521892T1 (de) 2011-09-15

Family

ID=29423281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03728889T ATE521892T1 (de) 2002-05-14 2003-05-14 Systeme und verfahren zum identifizieren des organtransplantationsrisikos

Country Status (7)

Country Link
US (2) US7244555B2 (de)
EP (1) EP1509771B1 (de)
AT (1) ATE521892T1 (de)
AU (1) AU2003234549A1 (de)
CA (1) CA2486947C (de)
ES (1) ES2372274T3 (de)
WO (1) WO2003098185A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138230B2 (en) 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
US7244555B2 (en) * 2002-05-14 2007-07-17 Renovak Inc Systems and methods for identifying organ transplant risk
ITFI20030058A1 (it) * 2003-03-06 2004-09-07 Univ Firenze Formulazioni farmaceutiche contenenti tiazolidinedioni
WO2005002416A2 (en) * 2003-06-04 2005-01-13 Joslin Diabetes Center, Inc. Predictors of renal disease
WO2005012907A1 (en) * 2003-08-01 2005-02-10 Renovar, Inc. Systems and methods for characterizing kidney diseases
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
ITFI20040243A1 (it) * 2004-11-25 2005-02-25 Paola Romagnani Metodo diagnostico per la previsione di rigetto di organo trapiantato
PE20061164A1 (es) 2005-02-16 2006-10-27 Schering Corp Piperazin-piperidinas sustituidas con pirazinilo con actividad antagonista de cxcr3
CA2598457A1 (en) 2005-02-16 2006-08-24 Schering Corporation Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
MX2007010067A (es) 2005-02-16 2007-12-07 Schering Corp Compuestos heterociclicos novedosos sustituidos con piridina o fenilo con actividad antagonista de cxcr3.
EP1858888B1 (de) 2005-02-16 2013-04-17 Merck Sharp & Dohme Corp. Heteroaryl-substituierte pyrazinyl-piperazin-piperidine mit cxcr3-antagonistischer aktivität
US7763616B2 (en) 2005-02-16 2010-07-27 Schering Corporation Piperazine-piperidines with CXCR3 antagonist activity
WO2006088837A2 (en) 2005-02-16 2006-08-24 Schering Corporation Heterocyclic substituted piperazines with cxcr3 antagonist activity
EP1996577B1 (de) 2006-03-21 2016-02-10 Merck Sharp & Dohme Corp. Heterocyclische substituierte pyridinverbindungen mit cxcr3-antagonistenaktivität
WO2008008453A1 (en) 2006-07-14 2008-01-17 Schering Corporation Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
NZ619918A (en) * 2008-10-21 2015-04-24 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
WO2011017685A1 (en) * 2009-08-07 2011-02-10 Rules-Based Medicine, Inc. Methods and devices for detecting kidney transplant rejection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340721A (en) * 1991-07-26 1994-08-23 Board Of Regents, The University Of Texas System Assay for free secretory component and methods for monitoring organ rejection
WO2001078708A1 (en) 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Treating graft rejection with cxcr3 inhibitors
US6964967B2 (en) * 2000-12-11 2005-11-15 Amgen, Inc. Substituted pyrido[2,3-d]pyrimidines and methods for their use
US7138230B2 (en) * 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
US7138229B2 (en) * 2002-12-06 2006-11-21 Renovar, Inc. Systems and methods for characterizing kidney diseases
US7244555B2 (en) 2002-05-14 2007-07-17 Renovak Inc Systems and methods for identifying organ transplant risk
WO2005002416A2 (en) 2003-06-04 2005-01-13 Joslin Diabetes Center, Inc. Predictors of renal disease
WO2005012907A1 (en) 2003-08-01 2005-02-10 Renovar, Inc. Systems and methods for characterizing kidney diseases
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
US20070134728A1 (en) * 2005-10-25 2007-06-14 Renovar Incorporated Systems and methods for characterizing conditions and diseases associated with organ transplantation and organ health

Also Published As

Publication number Publication date
EP1509771A4 (de) 2007-09-05
US7244555B2 (en) 2007-07-17
US20070287188A1 (en) 2007-12-13
AU2003234549A1 (en) 2003-12-02
AU2003234549A8 (en) 2003-12-02
CA2486947A1 (en) 2003-11-27
EP1509771A2 (de) 2005-03-02
ES2372274T3 (es) 2012-01-17
HK1073153A1 (en) 2005-09-23
US20030215886A1 (en) 2003-11-20
EP1509771B1 (de) 2011-08-24
WO2003098185A3 (en) 2004-02-19
CA2486947C (en) 2018-11-20
WO2003098185A2 (en) 2003-11-27
US7531301B2 (en) 2009-05-12

Similar Documents

Publication Publication Date Title
ATE521892T1 (de) Systeme und verfahren zum identifizieren des organtransplantationsrisikos
EP1962092A3 (de) Systeme und Methoden zur Charakterisierung von Nierenkrankheiten
EP1948014A4 (de) System und verfahren zur vorhersage eines kognitiven abbaus
NO20072721L (no) Polypeptides that bind BR3 and uses thereof
WO2004052175A3 (en) Methods for rapid identification of pathogens in humans and animals
DK1615992T3 (da) Prionproteinbindende materialer og fremgangsmåder til anvendelse
WO2004060278A3 (en) Methods for rapid identification of pathogens in humans and animals
DK1668368T3 (da) Detektion af histon-modifikation i cellefrie nukleosomer
EP1782036A4 (de) Gasprobenkonditionierungssystem
DK1175511T3 (da) Fremgangsmåde og testsæt til opsamling og opbevaring af biologiske pröver
EP1953736A4 (de) Stereo-codierungseinrichtung und stereosignal-prädiktionsverfahren
DE602007013524D1 (de) Erkennung und vorhersage von frühgeburten
WO2007111938A3 (en) Inflammation-inhibitory serum factors and uses thereof
FI20050727L (fi) Vieraiden hiukkasten tribologinen analyysijärjestelmä
EP1901183A4 (de) Multiprozessorsystem und informationsverarbeitungsverfahren
WO2004057341A3 (en) Cvd assay
DE60302527D1 (de) Messsystem für lebende Körper
BRPI0515079A (pt) marcadores imobilizados e métodos de detecção de prions conformacionalmente alterados
FR2876727B1 (fr) Procede d'activation d'un systeme anti-pincement
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
DE602004020545D1 (de) Datenbank-Suchsystem
ATE541945T1 (de) Nachweis und quantifizierung fäkaler verunreinigungen in umweltproben
ATE277353T1 (de) Tau als marker für frühe schäden des zentralen nervensystems
ATE470153T1 (de) Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie
WO2007050588A3 (en) Systems and methods for characterizing conditions of organs for transplantation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties